Refractive Reports

The 2025 China Ophthalmic Market Report delivers a comprehensive analysis of China’s rapidly evolving ophthalmic sector, analyzing the demographic trends and economic conditions that will shape the future of the market. The report offers deep insights into disease prevalence, highlights commercialized products and promising pipeline assets, and forecasts unit demand, sales revenue, and market performance through 2030. Competitive dynamics are thoroughly analyzed across product categories, and the report provides detailed profiles of 32 major competitors, their product portfolios, strategic positions, and future outlooks.  

The “2025 Presbyopia Correction Market Report” offers a detailed analysis of the global market for surgical and pharmaceutical presbyopia treatments and forecasts market performance through 2030. It includes regional and global market sizing, identification of key trends, and discussion of the factors most likely to shape future growth.

This report examines procedure volumes, estimates serviceable patient populations, and forecasts the presbyopia markets for laser vision correction procedures (LASIK, lenticule extraction, and surface ablation), presbyopia-correcting IOLs (PC-IOLs), and pharmaceutical drops by region through 2030.

The report is designed for industry stakeholders—manufacturers, market analysts, ophthalmologists, optometrists, and investors—seeking a clear and actionable view of the presbyopia correction market and its potential over the next five years.

Market Scope’s "2025 Refractive Error Model" offers extensive country-level prevalence data and five-year forecasts for five refractive error categories by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Market Scope’s “2025 European Five Ophthalmic Market Report” dives into Western Europe’s top five ophthalmic markets—France, Germany, Italy, Spain, and the United Kingdom—exploring 11 ophthalmic submarkets with insights on crucial trends and factors for success. The report reviews current market landscapes, projects market performance through 2030, forecasts disease prevalence, analyzes treatment volumes, and reviews emerging technologies and profiles key competitors. 

The “2024 Ophthalmic Landscape Report” offers a high-level analysis of the ophthalmic market by region and subspecialty and forecasts market performance of nine product categories through 2029. The report analyzes important trends, reviews key factors for future success, comprehensively details the competitive landscape in ophthalmology, and compares the ophthalmic sector across health care and other related markets. 

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Refractive Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

Market Scope’s "2024 Refractive Error Model" offers extensive country-level prevalence data and five-year forecasts for five refractive error categories by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

The “2024 Refractive Surgery Market Report” analyzes the global refractive and presbyopia-correcting market, identifying important trends and key factors for future success. It focuses on the 2024 refractive and presbyopia-correcting surgical market and forecasts market growth and evolution over the next five years. Included are discussions and market estimates for LASIK, lenticular extraction, phakic IOLs, corneal inlays, refractive lens exchange (RLE), and other technologies that may disrupt the market. 

Product demand is forecast in units and dollars, and market shares are analyzed by product category. Sixteen market competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

Market Scope’s “2024 European Five Ophthalmic Market Report” analyzes the ophthalmic market in Western Europe’s five largest economies, discussing important trends and key factors for future success in 11 ophthalmic submarkets. The report includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. It profiles ophthalmic companies in the five markets, provides analysis of current markets, and offers five-year forecasts of market performance.

The “2024 United States Refractive Atlas” provides a geographic analysis of the US refractive market in 85 metropolitan areas. Market Scope’s MedOp Index™ Analysis is used to identify the potential for refractive surgery and considers many factors for each geography, including:  population age distribution, refractive error, income/buying power, overall health, education level, and location of refractive surgeons and LVC centers. High-opportunity populations and benchmarking comparisons are provided for each metropolitan area. Additionally, the atlas provides a comprehensive directory of all US practices offering refractive surgery. Market Scope also offers customization of atlas data to align with sales territories or specific geographic areas.